Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Crowe

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Drug Development and Industrial Pharmacy|November 6, 2018
Oral delivery of the anti-tumor necrosis factor α domain antibody, V565, results in high intestinal and fecal concentrations with minimal systemic exposure in cynomolgus monkeysJ Scott Crowe, Kevin J Roberts, Timothy M Carlton, et al.
Scientific Reports|October 3, 2019
Oral Anti-Tumour Necrosis Factor Domain Antibody V565 Provides High Intestinal Concentrations, and Reduces Markers of Inflammation in Ulcerative Colitis PatientsSuhail Nurbhai, Kevin J Roberts, Timothy M Carlton, et al.
International Journal of Bipolar Disorders|June 25, 2015
Development of a bipolar disorder biobank: differential phenotyping for subsequent biomarker analysesMark A Frye, Susan L McElroy, Manuel Fuentes, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Drug Development and Industrial Pharmacy|November 6, 2018
Oral delivery of the anti-tumor necrosis factor α domain antibody, V565, results in high intestinal and fecal concentrations with minimal systemic exposure in cynomolgus monkeysJ Scott Crowe, Kevin J Roberts, Timothy M Carlton, et al.
Scientific Reports|October 3, 2019
Oral Anti-Tumour Necrosis Factor Domain Antibody V565 Provides High Intestinal Concentrations, and Reduces Markers of Inflammation in Ulcerative Colitis PatientsSuhail Nurbhai, Kevin J Roberts, Timothy M Carlton, et al.
International Journal of Bipolar Disorders|June 25, 2015
Development of a bipolar disorder biobank: differential phenotyping for subsequent biomarker analysesMark A Frye, Susan L McElroy, Manuel Fuentes, et al.
Pageof 3